Anna Agren

Summary

Affiliation: Karolinska University Hospital
Country: Sweden

Publications

  1. doi Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system
    Anna Agren
    Anna Ågren, MD, PhD, Coagulation Unit, Hematology Center, Karolinska University Hospital, 171 76 Stockholm, Sweden, Tel 46 8 517 73373, Fax 46 8 51775084, E mail
    Thromb Haemost 117:75-85. 2017
  2. doi Increased incorporation of antiplasmin into the fibrin network in patients with type 1 diabetes
    Anna Agren
    Coagulation Unit, Division of Haematology, Department of Medicine, Karolinska University Hospital, Stockholm, SwedenDepartment of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden
    Diabetes Care 37:2007-14. 2014
  3. doi Thromboelastography (TEG®) compared to conventional coagulation tests in surgical patients--a laboratory evaluation
    Anna Agren
    Department of Medicine, Division of Haematology, Coagulation Unit, Karolinska University Hospital, Stockholm, Sweden
    Scand J Clin Lab Invest 73:214-20. 2013
  4. ncbi Low PAI-1 activity in relation to the risk for perioperative bleeding complications in transurethral resection of the prostate
    A Agren
    Department of Hematology, Coagulation Unit, Karolinska University Hospital, S 171 76 Stockholm, Sweden
    Thromb Res 119:715-21. 2007
  5. ncbi Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity
    Anna Agren
    Department of Hematology, Coagulation Unit, Karolinska University Hospital, Stockholm, Sweden
    Blood Coagul Fibrinolysis 18:657-60. 2007
  6. doi Low PAI-1 activity in relation to inflammatory parameters, insulin profile and body mass index
    A Agren
    Department of Medicine, Karolinska Institute, Stockholm, Sweden
    J Intern Med 264:586-92. 2008
  7. doi TEG® functional fibrinogen analysis may overestimate fibrinogen levels
    Anna Agren
    From the Department of Medicine, Division of Hematology, Coagulation Unit, Karolinska University Hospital, Stockholm, Sweden Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden Department of Anesthesiology and Intensive Care, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden and Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Anesth Analg 118:933-5. 2014
  8. doi Haemostasis monitored in stored red blood cells, plasma and platelet concentrates in the proportion of 4 :  4 :  1 diluted with crystalloids and colloids
    Anna Agren
    aDepartment of Medicine, Division of Hematology, Coagulation Unit, Karolinska Institutet and Karolinska University Hospital bDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet cDepartment of Medicine, Division of Hematology, Karolinska Institutet and Karolinska University Hospital dDepartment of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital eDepartment of Anaesthesiology and Intensive Care, Karolinska University Hospital and Karolinska Institutet fDepartment of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
    Blood Coagul Fibrinolysis 27:334-9. 2016
  9. doi Detection of elevated INR by thromboelastometry and thromboelastography in warfarin treated patients and healthy controls
    David E Schmidt
    Department of Medicine, Division of Hematology, Coagulation Unit, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden Utrecht University Medical Center, Utrecht, The Netherlands
    Thromb Res 135:1007-11. 2015
  10. doi Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndrome
    Anna Vikerfors
    Karolinska Institutet, Department of Medicine Solna, Unit of Rheumatology, Karolinska University Hospital, Stockholm, Sweden Electronic address
    Thromb Res 133:936-44. 2014

Collaborators

Detail Information

Publications15

  1. doi Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system
    Anna Agren
    Anna Ågren, MD, PhD, Coagulation Unit, Hematology Center, Karolinska University Hospital, 171 76 Stockholm, Sweden, Tel 46 8 517 73373, Fax 46 8 51775084, E mail
    Thromb Haemost 117:75-85. 2017
    ..The poor prediction of bleeding by conventional laboratory monitoring in VWD-3 patients might be related to insufficient restoration of platelet-dependent thrombus formation...
  2. doi Increased incorporation of antiplasmin into the fibrin network in patients with type 1 diabetes
    Anna Agren
    Coagulation Unit, Division of Haematology, Department of Medicine, Karolinska University Hospital, Stockholm, SwedenDepartment of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden
    Diabetes Care 37:2007-14. 2014
    ..In the current study, we characterized antiplasmin incorporation into fibrin in relation to other fibrinolytic compounds in patients with type 1 diabetes...
  3. doi Thromboelastography (TEG®) compared to conventional coagulation tests in surgical patients--a laboratory evaluation
    Anna Agren
    Department of Medicine, Division of Haematology, Coagulation Unit, Karolinska University Hospital, Stockholm, Sweden
    Scand J Clin Lab Invest 73:214-20. 2013
    ..g. thromboelastography (TEG(®)) and conventional methods (platelet count, aPTT, INR and fibrinogen). Considering the vast experience of conventional methods it is important to investigate how well the methods correspond...
  4. ncbi Low PAI-1 activity in relation to the risk for perioperative bleeding complications in transurethral resection of the prostate
    A Agren
    Department of Hematology, Coagulation Unit, Karolinska University Hospital, S 171 76 Stockholm, Sweden
    Thromb Res 119:715-21. 2007
    ..The aim of this study was to investigate prospectively whether low PAI-1 activity increases the risk for perioperative bleeding in patients undergoing transurethral resection of prostate, an organ with high fibrinolytic activity...
  5. ncbi Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity
    Anna Agren
    Department of Hematology, Coagulation Unit, Karolinska University Hospital, Stockholm, Sweden
    Blood Coagul Fibrinolysis 18:657-60. 2007
    ..0 U/ml. The coagulation activity under normal conditions, as measured by D-dimer, did not differ between the two patient subsets. The results support our previous definition of low PAI-1 as activity below 1.0 U/ml...
  6. doi Low PAI-1 activity in relation to inflammatory parameters, insulin profile and body mass index
    A Agren
    Department of Medicine, Karolinska Institute, Stockholm, Sweden
    J Intern Med 264:586-92. 2008
    ..The purpose of this study was to investigate if patients with low PAI-1 activity have a lack of inflammatory response or a low insulin level...
  7. doi TEG® functional fibrinogen analysis may overestimate fibrinogen levels
    Anna Agren
    From the Department of Medicine, Division of Hematology, Coagulation Unit, Karolinska University Hospital, Stockholm, Sweden Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden Department of Anesthesiology and Intensive Care, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden and Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Anesth Analg 118:933-5. 2014
    ..The fibrinogen level may be overestimated when assessed using TEG® compared with the fibrinogen plasma concentration measured by the conventional method. ..
  8. doi Haemostasis monitored in stored red blood cells, plasma and platelet concentrates in the proportion of 4 :  4 :  1 diluted with crystalloids and colloids
    Anna Agren
    aDepartment of Medicine, Division of Hematology, Coagulation Unit, Karolinska Institutet and Karolinska University Hospital bDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet cDepartment of Medicine, Division of Hematology, Karolinska Institutet and Karolinska University Hospital dDepartment of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital eDepartment of Anaesthesiology and Intensive Care, Karolinska University Hospital and Karolinska Institutet fDepartment of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
    Blood Coagul Fibrinolysis 27:334-9. 2016
    ..Dilution with Ringer's acetate and albumin resulted in moderate deterioration, while dilution with HES showed severely impaired haemostasis. ..
  9. doi Detection of elevated INR by thromboelastometry and thromboelastography in warfarin treated patients and healthy controls
    David E Schmidt
    Department of Medicine, Division of Hematology, Coagulation Unit, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden Utrecht University Medical Center, Utrecht, The Netherlands
    Thromb Res 135:1007-11. 2015
    ..The diagnostic potential of whole blood viscoelastic tests thromboelastography (TEG®) and thromboelastometry (ROTEM®) to detect warfarin-induced INR elevation remains elusive...
  10. doi Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndrome
    Anna Vikerfors
    Karolinska Institutet, Department of Medicine Solna, Unit of Rheumatology, Karolinska University Hospital, Stockholm, Sweden Electronic address
    Thromb Res 133:936-44. 2014
    ..We investigated the tightness of fibrin clot and fibrinolytic function in plasma samples from APS patients compared with two control groups...
  11. doi Strategies and outcomes of periprocedural bridging therapy with low-molecular-weight heparin in patients with mechanical heart valves
    Jacqueline M Schulman
    Department of Medicine, Coagulation Unit, Hematology Center, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden
    J Thromb Thrombolysis 40:430-6. 2015
    ..For patients with MHV receiving perioperative bridging with LMWH, the major predictor for MBE is the bleeding risk of the surgery. ..
  12. pmc In vitro combinations of red blood cell, plasma and platelet components evaluated by thromboelastography
    Anna Agren
    Department of Medicine, Division of Haematology, Coagulation Unit, Karolinska University Hospital, Stockholm, Sweden Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden
    Blood Transfus 12:491-6. 2014
    ..The aim of this study was to investigate how different combinations of blood components affect in vitro whole blood clotting measured by thromboelastography...
  13. doi Fibrin clot properties and haemostatic function in men and women with type 1 diabetes
    Sara Tehrani
    Sara Tehrani, MD, Division of Medicine, Danderyd Hospital, 18288 Stockholm, Sweden, Tel 46 8 123 55000, Fax 46 8 123 56187, E mail
    Thromb Haemost 113:312-8. 2015
    ..Tighter fibrin clot formation in younger women, as suggested by our results, may affect their future cardiovascular risk and should be investigated in a larger population. ..
  14. doi Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy
    Ammar Majeed
    Coagulation Unit, Hematology Center, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden
    Thromb Res 129:146-51. 2012
    ..There is uncertainty regarding the efficacy and incidence of thromboembolic events in patients treated with prothrombin complex concentrates (PCC) for the emergency reversal of warfarin effect...
  15. ncbi Evaluation of low PAI-1 activity as a risk factor for hemorrhagic diathesis
    A Agren
    Department of Hematology, Coagulation Unit, King Gustaf V Research Institute, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
    J Thromb Haemost 4:201-8. 2006
    ..Prospective studies of the epidemiology and clinical significance of low plasminogen activator inhibitor type 1 (PAI-1) activity are lacking...